189 related articles for article (PubMed ID: 15878303)
1. Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy.
Efferth T
Drug Resist Updat; 2005; 8(1-2):85-97. PubMed ID: 15878303
[TBL] [Abstract][Full Text] [Related]
2. Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside.
Efferth T
Planta Med; 2007 Apr; 73(4):299-309. PubMed ID: 17354163
[TBL] [Abstract][Full Text] [Related]
3. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells.
Efferth T
Curr Drug Targets; 2006 Apr; 7(4):407-21. PubMed ID: 16611029
[TBL] [Abstract][Full Text] [Related]
5. Molecular modes of action of artesunate in tumor cell lines.
Efferth T; Sauerbrey A; Olbrich A; Gebhart E; Rauch P; Weber HO; Hengstler JG; Halatsch ME; Volm M; Tew KD; Ross DD; Funk JO
Mol Pharmacol; 2003 Aug; 64(2):382-94. PubMed ID: 12869643
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether.
Efferth T; Olbrich A; Bauer R
Biochem Pharmacol; 2002 Aug; 64(4):617-23. PubMed ID: 12167480
[TBL] [Abstract][Full Text] [Related]
7. The anti-malarial artesunate is also active against cancer.
Efferth T; Dunstan H; Sauerbrey A; Miyachi H; Chitambar CR
Int J Oncol; 2001 Apr; 18(4):767-73. PubMed ID: 11251172
[TBL] [Abstract][Full Text] [Related]
8. Factors determining sensitivity or resistance of tumor cell lines towards artesunate.
Sertel S; Eichhorn T; Sieber S; Sauer A; Weiss J; Plinkert PK; Efferth T
Chem Biol Interact; 2010 Apr; 185(1):42-52. PubMed ID: 20144594
[TBL] [Abstract][Full Text] [Related]
9. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
[TBL] [Abstract][Full Text] [Related]
10. [Review of the use of artemisinin and its derivatives in the treatment of malaria].
Van der Meersch H
J Pharm Belg; 2005; 60(1):23-9. PubMed ID: 15828489
[TBL] [Abstract][Full Text] [Related]
11. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid.
Ro DK; Ouellet M; Paradise EM; Burd H; Eng D; Paddon CJ; Newman JD; Keasling JD
BMC Biotechnol; 2008 Nov; 8():83. PubMed ID: 18983675
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin and derivatives in the treatment of uncomplicated malaria.
White NJ; Olliaro P
Med Trop (Mars); 1998; 58(3 Suppl):54-6. PubMed ID: 10212899
[TBL] [Abstract][Full Text] [Related]
13. From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements.
Haynes RK
Curr Top Med Chem; 2006; 6(5):509-37. PubMed ID: 16719805
[TBL] [Abstract][Full Text] [Related]
14. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin.
Bhisutthibhan J; Pan XQ; Hossler PA; Walker DJ; Yowell CA; Carlton J; Dame JB; Meshnick SR
J Biol Chem; 1998 Jun; 273(26):16192-8. PubMed ID: 9632675
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines.
Efferth T; Oesch F
Biochem Pharmacol; 2004 Jul; 68(1):3-10. PubMed ID: 15183112
[TBL] [Abstract][Full Text] [Related]
16. Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.
Duffey M; Sanchez CP; Lanzer M
Malar J; 2018 Mar; 17(1):121. PubMed ID: 29558913
[TBL] [Abstract][Full Text] [Related]
17. The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes.
Peters W; Li ZL; Robinson BL; Warhurst DC
Ann Trop Med Parasitol; 1986 Oct; 80(5):483-9. PubMed ID: 3307655
[TBL] [Abstract][Full Text] [Related]
18. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.
Vivas L; Rattray L; Stewart L; Bongard E; Robinson BL; Peters W; Croft SL
Acta Trop; 2008 Mar; 105(3):222-8. PubMed ID: 18279817
[TBL] [Abstract][Full Text] [Related]
19. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
Nosten F; van Vugt M; Price R; Luxemburger C; Thway KL; Brockman A; McGready R; ter Kuile F; Looareesuwan S; White NJ
Lancet; 2000 Jul; 356(9226):297-302. PubMed ID: 11071185
[TBL] [Abstract][Full Text] [Related]
20. Overview of clinical studies on artemisinin derivatives in Thailand.
Looareesuwan S
Trans R Soc Trop Med Hyg; 1994 Jun; 88 Suppl 1():S9-11. PubMed ID: 8053034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
